Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

US Patent 9549934 · Granted Jan 24, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinuclidine derivatives and medicinal compositions containing the same2020
Combinations comprising MABA compounds and corticosteroids2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Quinuclidine derivatives and medicinal compositions containing the same2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2017